Golniški simpozij 2011 Klinična farmacija zbornik ... - Bolnišnica Golnik

8. Limei Y, Weihong G, Feng Y, Huaijun Z. Impact of VKORC1 gene polymorphismon interindividual and interethnic warfarin dosage requirement - A systematicreview and meta analysis. Thromb. Res. 2010 125:e159–e166.9. Bachmann KA. Lexi-Comp's drug interaction handbook, 2.izdaja, Lexi-Comp,Hudson, Ohio, 2004 ter online dostop monografije z varfarinom (13.9.2011).10. Lu Y, Won KA, Nelson BJ, Qi D, Rausch DJ, Asinger RW. Characteristics of theamiodarone-warfarin interaction during long-term follow-up. Am J Health SystPharm. 2008 65(10): 947-52.11. Parrish RH, Pazdur DE, O'Donnell PJ. Effect of carbamazepine initiation anddiscontinuation on antithrombotic control in patient receiving warfarin: case reportand review of the literature. Pharmacotherapy, 2006; 26(11): 1650-1653.12. Povzetek glavnih značilnosti zdravila: Marevan. Datum zadnje revizije13.01.2010. Dostopno na www.zdravila.net13. Weathermon R, Crabb DW. Alcohol and Medication Interactions. AlcoholResearch & Health, 1999;23 (1):40-5414. Levine M, Raskob G, Beyth R, Kearon C, Schulman S. Hemorrhagiccomplications of anticoagulant treatment. Chest, 2004; 126 : 287S-310S.15. Hughes GJ, Patel PN and Saxena N. Effect of Acetaminophen on InternationalNormalized Ratio: Clinician Awareness and Patient EducationPharmacotherapy, 2011;31(6):591-597.16. Mahé I, Bertrand N, Drouet L, Simoneau G et al. Paracetamol: a haemorrhagicrisk factor in patients on warfarin. Br J Clin Pharmacol, 2005; 59(3): 371–374.